Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by silibinin

Involvement of protein kinase C

So N. Kang, Mi H. Lee, Kyeong Man Kim, Dae Ho Cho, Tae Sung Kim

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The effect of silibinin, an active component of Silybum marianum, on cellular differentiation was investigated in the human promyelocytic leukemia HL-60 cell culture system. Treatment of HL-60 cells with silibinin inhibited cellular proliferation and induced cellular differentiation in a dose-dependent manner. Cytofluorometric analysis and morphologic studies indicated that silibinin induced differentiation of HL-60 cells predominantly into monocytes. Importantly, strongly synergistic induction of differentiation into monocytes was observed when silibinin was combined with 5 nM 1α,25-dihydroxyvitamin D3 [1,25-(OH)2D3], a well-known differentiation inducer of HL-60 cells into the monocytic lineage. Silibinin enhanced protein kinase C (PKC) activity and increased protein levels of both PKCα and PKCβ in 1,25-(OH)2D3-treated HL-60 cells. PKC and extracellular signal-regulated kinase (ERK) inhibitors significantly inhibited HL-60 cell differentiation induced by silibinin alone or in combination with 1,25-(OH)2D3, indicating that PKC and ERK may be involved in silibinin-induced HL-60 cell differentiation.

Original languageEnglish
Pages (from-to)1487-1495
Number of pages9
JournalBiochemical Pharmacology
Volume61
Issue number12
DOIs
Publication statusPublished - 2001 Jun 15
Externally publishedYes

Fingerprint

HL-60 Cells
Protein Kinase C
Monocytes
Cell Differentiation
Leukemia
Extracellular Signal-Regulated MAP Kinases
Milk Thistle
Calcitriol
silybin
Cell culture
Cell Culture Techniques
Cell Proliferation
Proteins

Keywords

  • 1α,25-Dihydroxyvitamin D
  • Extracellular signal-regulated kinase
  • HL-60 cell differentiation
  • Protein kinase C
  • Silibinin

ASJC Scopus subject areas

  • Pharmacology

Cite this

Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by silibinin : Involvement of protein kinase C. / Kang, So N.; Lee, Mi H.; Kim, Kyeong Man; Cho, Dae Ho; Kim, Tae Sung.

In: Biochemical Pharmacology, Vol. 61, No. 12, 15.06.2001, p. 1487-1495.

Research output: Contribution to journalArticle

@article{1ac200a7d9fa464f881dc1cde55a14de,
title = "Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by silibinin: Involvement of protein kinase C",
abstract = "The effect of silibinin, an active component of Silybum marianum, on cellular differentiation was investigated in the human promyelocytic leukemia HL-60 cell culture system. Treatment of HL-60 cells with silibinin inhibited cellular proliferation and induced cellular differentiation in a dose-dependent manner. Cytofluorometric analysis and morphologic studies indicated that silibinin induced differentiation of HL-60 cells predominantly into monocytes. Importantly, strongly synergistic induction of differentiation into monocytes was observed when silibinin was combined with 5 nM 1α,25-dihydroxyvitamin D3 [1,25-(OH)2D3], a well-known differentiation inducer of HL-60 cells into the monocytic lineage. Silibinin enhanced protein kinase C (PKC) activity and increased protein levels of both PKCα and PKCβ in 1,25-(OH)2D3-treated HL-60 cells. PKC and extracellular signal-regulated kinase (ERK) inhibitors significantly inhibited HL-60 cell differentiation induced by silibinin alone or in combination with 1,25-(OH)2D3, indicating that PKC and ERK may be involved in silibinin-induced HL-60 cell differentiation.",
keywords = "1α,25-Dihydroxyvitamin D, Extracellular signal-regulated kinase, HL-60 cell differentiation, Protein kinase C, Silibinin",
author = "Kang, {So N.} and Lee, {Mi H.} and Kim, {Kyeong Man} and Cho, {Dae Ho} and Kim, {Tae Sung}",
year = "2001",
month = "6",
day = "15",
doi = "10.1016/S0006-2952(01)00626-8",
language = "English",
volume = "61",
pages = "1487--1495",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by silibinin

T2 - Involvement of protein kinase C

AU - Kang, So N.

AU - Lee, Mi H.

AU - Kim, Kyeong Man

AU - Cho, Dae Ho

AU - Kim, Tae Sung

PY - 2001/6/15

Y1 - 2001/6/15

N2 - The effect of silibinin, an active component of Silybum marianum, on cellular differentiation was investigated in the human promyelocytic leukemia HL-60 cell culture system. Treatment of HL-60 cells with silibinin inhibited cellular proliferation and induced cellular differentiation in a dose-dependent manner. Cytofluorometric analysis and morphologic studies indicated that silibinin induced differentiation of HL-60 cells predominantly into monocytes. Importantly, strongly synergistic induction of differentiation into monocytes was observed when silibinin was combined with 5 nM 1α,25-dihydroxyvitamin D3 [1,25-(OH)2D3], a well-known differentiation inducer of HL-60 cells into the monocytic lineage. Silibinin enhanced protein kinase C (PKC) activity and increased protein levels of both PKCα and PKCβ in 1,25-(OH)2D3-treated HL-60 cells. PKC and extracellular signal-regulated kinase (ERK) inhibitors significantly inhibited HL-60 cell differentiation induced by silibinin alone or in combination with 1,25-(OH)2D3, indicating that PKC and ERK may be involved in silibinin-induced HL-60 cell differentiation.

AB - The effect of silibinin, an active component of Silybum marianum, on cellular differentiation was investigated in the human promyelocytic leukemia HL-60 cell culture system. Treatment of HL-60 cells with silibinin inhibited cellular proliferation and induced cellular differentiation in a dose-dependent manner. Cytofluorometric analysis and morphologic studies indicated that silibinin induced differentiation of HL-60 cells predominantly into monocytes. Importantly, strongly synergistic induction of differentiation into monocytes was observed when silibinin was combined with 5 nM 1α,25-dihydroxyvitamin D3 [1,25-(OH)2D3], a well-known differentiation inducer of HL-60 cells into the monocytic lineage. Silibinin enhanced protein kinase C (PKC) activity and increased protein levels of both PKCα and PKCβ in 1,25-(OH)2D3-treated HL-60 cells. PKC and extracellular signal-regulated kinase (ERK) inhibitors significantly inhibited HL-60 cell differentiation induced by silibinin alone or in combination with 1,25-(OH)2D3, indicating that PKC and ERK may be involved in silibinin-induced HL-60 cell differentiation.

KW - 1α,25-Dihydroxyvitamin D

KW - Extracellular signal-regulated kinase

KW - HL-60 cell differentiation

KW - Protein kinase C

KW - Silibinin

UR - http://www.scopus.com/inward/record.url?scp=0035877237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035877237&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(01)00626-8

DO - 10.1016/S0006-2952(01)00626-8

M3 - Article

VL - 61

SP - 1487

EP - 1495

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 12

ER -